Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price target lifted by Wedbush from $185.00 to $194.00 in a report released on Monday,Benzinga reports. Wedbush currently has an outperform rating on the stock. NBIX has been the topic of a number of other reports. Royal Bank Of Canada upped their price objective on shares of […]

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its price target increased by TD Cowen from $200.00 to $220.00 in a research report released on Friday morning,Benzinga reports. The firm currently has a buy rating on the stock. Several other research firms have also issued reports on NBIX. Morgan Stanley upped their price target on shares […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price target lifted by research analysts at TD Cowen from $200.00 to $220.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s price target would indicate a potential upside of 31.98% from the company’s previous […]

Equinix (NASDAQ:EQIX – Get Free Report) had its price objective lifted by research analysts at TD Cowen from $1,143.00 to $1,166.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the financial services provider’s stock. TD Cowen’s price objective points to a potential upside […]

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price hoisted by Guggenheim from $175.00 to $200.00 in a research report sent to investors on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities research analysts have also issued research reports about the company. BMO Capital Markets raised their target […]